Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 EUR | -0.73% | -19.80% | -51.02% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | 383M 409M | Sales 2022 | 197M 210M | Capitalization | 141M 151M |
---|---|---|---|---|---|
Net income 2021 | 104M 111M | Net income 2022 | 15M 16.04M | EV / Sales 2021 | 0.5 x |
Net cash position 2021 | 96.72M 103M | Net cash position 2022 | 35.09M 37.52M | EV / Sales 2022 | 0.54 x |
P/E ratio 2021 |
2.63
x | P/E ratio 2022 |
9.08
x | Employees | 551 |
Yield 2021 |
7.6% | Yield 2022 |
-
| Free-Float | 39.43% |
1 day | -0.73% | ||
1 week | -19.80% | ||
Current month | -15.06% | ||
1 month | -16.27% | ||
3 months | -48.88% | ||
6 months | -51.25% | ||
Current year | -51.02% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.09 | -0.73% | 9,119 |
24-04-25 | 4.12 | -23.13% | 69,990 |
24-04-24 | 5.36 | +1.13% | 5,754 |
24-04-23 | 5.3 | +0.76% | 10,618 |
24-04-22 | 5.26 | +3.14% | 6,526 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-51.02% | 46.99M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- ALBIO Stock